Report: Developing Opportunities within Main Street Capital, United States Cellular, FibroGen, Cardiovascular, CDW, and ANSYS — Future Expectations, Projections Moving into 2018

NEW YORK, March 01, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Main Street Capital Corporation (NYSE:MAIN), United States Cellular Corporation (NYSE:USM), FibroGen, Inc (NASDAQ:FGEN), Cardiovascular Systems, Inc. (NASDAQ:CSII), CDW Corporation (NASDAQ:CDW), and ANSYS, Inc. (NASDAQ:ANSS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MAIN DOWNLOAD: http://Fundamental-Markets.com/register/?so=MAIN
USM DOWNLOAD: http://Fundamental-Markets.com/register/?so=USM
FGEN DOWNLOAD: http://Fundamental-Markets.com/register/?so=FGEN
CSII DOWNLOAD: http://Fundamental-Markets.com/register/?so=CSII
CDW DOWNLOAD: http://Fundamental-Markets.com/register/?so=CDW
ANSS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ANSS

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Main Street Capital Corporation (NYSE:MAIN), United States Cellular Corporation (NYSE:USM), FibroGen, Inc (NASDAQ:FGEN), Cardiovascular Systems, Inc. (NASDAQ:CSII), CDW Corporation (NASDAQ:CDW), and ANSYS, Inc. (NASDAQ:ANSS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

MAIN STREET CAPITAL CORPORATION (MAIN) REPORT OVERVIEW

Main Street Capital's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Main Street Capital reported revenue of $55.80MM vs $46.83MM (up 19.14%) and basic earnings per share $1.07 vs $0.92 (up 16.30%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Main Street Capital reported revenue of $205.74MM vs $178.34MM (up 15.37%) and basic earnings per share $3.01 vs $2.67 (up 12.73%). Main Street Capital is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.56. The estimated EPS forecast for the next fiscal year is $2.48 and is expected to report on February 28th, 2019.

To read the full Main Street Capital Corporation (MAIN) report, download it here: http://Fundamental-Markets.com/register/?so=MAIN

-----------------------------------------

UNITED STATES CELLULAR CORPORATION (USM) REPORT OVERVIEW

United States Cellular's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, United States Cellular reported revenue of $1,028.00MM vs $1,006.00MM (up 2.19%) and basic earnings per share $3.20 vs -$0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, United States Cellular reported revenue of $3,890.00MM vs $3,990.00MM (down 2.51%) and basic earnings per share $0.14 vs $0.56 (down 75.00%). United States Cellular is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $0.49 and is expected to report on February 22nd, 2019.

To read the full United States Cellular Corporation (USM) report, download it here: http://Fundamental-Markets.com/register/?so=USM

-----------------------------------------

FIBROGEN, INC (FGEN) REPORT OVERVIEW

FibroGen's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, FibroGen reported revenue of $27.27MM vs $30.10MM (down 9.40%) and basic earnings per share -$0.50 vs -$0.38. For the twelve months ended December 31st, 2016 vs December 31st, 2015, FibroGen reported revenue of $179.58MM vs $180.83MM (down 0.69%) and basic earnings per share -$0.98 vs -$1.42. FibroGen is expected to report earnings on February 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.54. The estimated EPS forecast for the next fiscal year is -$1.11 and is expected to report on February 27th, 2018.

To read the full FibroGen, Inc (FGEN) report, download it here: http://Fundamental-Markets.com/register/?so=FGEN

-----------------------------------------

CARDIOVASCULAR SYSTEMS, INC. (CSII) REPORT OVERVIEW

Cardiovascular's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Cardiovascular reported revenue of $52.63MM vs $50.04MM (up 5.17%) and basic earnings per share -$0.01 vs $0.03. For the twelve months ended June 30th, 2017 vs June 30th, 2016, Cardiovascular reported revenue of $204.91MM vs $178.18MM (up 15.00%) and basic earnings per share -$0.06 vs -$1.72. Cardiovascular is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.03. The estimated EPS forecast for the next fiscal year is $0.10 and is expected to report on August 1st, 2018.

To read the full Cardiovascular Systems, Inc. (CSII) report, download it here: http://Fundamental-Markets.com/register/?so=CSII

-----------------------------------------

CDW CORPORATION (CDW) REPORT OVERVIEW

CDW's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, CDW reported revenue of $4,033.90MM vs $3,708.20MM (up 8.78%) and basic earnings per share $0.84 vs $0.78 (up 7.69%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, CDW reported revenue of $13,981.90MM vs $12,988.70MM (up 7.65%) and basic earnings per share $2.59 vs $2.37 (up 9.28%). CDW is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.71. The estimated EPS forecast for the next fiscal year is $5.06 and is expected to report on February 6th, 2019.

To read the full CDW Corporation (CDW) report, download it here: http://Fundamental-Markets.com/register/?so=CDW

-----------------------------------------

ANSYS, INC. (ANSS) REPORT OVERVIEW

ANSYS's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, ANSYS reported revenue of $302.34MM vs $270.63MM (up 11.72%) and basic earnings per share $0.62 vs $0.82 (down 24.39%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ANSYS reported revenue of $1,095.25MM vs $988.47MM (up 10.80%) and basic earnings per share $3.05 vs $3.05 (unchanged). ANSYS is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.81. The estimated EPS forecast for the next fiscal year is $4.77 and is expected to report on February 20th, 2019.

To read the full ANSYS, Inc. (ANSS) report, download it here: http://Fundamental-Markets.com/register/?so=ANSS

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.